Papers - IINO Chikara
-
‹一般演題抄録›日本食スコア「12-component modified Japanese Diet Index ( mJDI12 ) が口腔・腸内細菌叢へ及ぼす影響についての縦断研究
佐藤 諭, 珍田 大輔, 飯野 勢, 沢田 かほり, 三上 達也, 中路 重之, 櫻庭 裕丈
弘前医学 75 ( 1 ) 79 2024.10
-
‹一般演題抄録›一般住民における食事パターンが Metabolic dysfunction-associated steatotic liver diseaseに与える影響についての検討
笹田 貴史, 佐藤 諭, 飯野 勢, 舘田 哲幸, 五十嵐 剛, 三上 達也, 中路 重之, 櫻庭 裕丈
弘前医学 75 ( 1 ) 79 2024.10
-
Epidemiological Study on the Interaction between the PNPLA3 (rs738409) and Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Satoshi Sato, Chikara Iino, Takafumi Sasada, Go Soma, Keisuke Furusawa, Kenta Yoshida, Kaori Sawada, Tatsuya Mikami, Shigeyuki Nakaji, Hirotake Sakuraba, Shinsaku Fukuda
Genes 15 ( 9 ) 2024.9
-
Role of the gut microbiota in nonalcoholic fatty liver disease, the ability of equol produce and Helicobacter pylori infection
Hirosaki Medical Journal 74 ( 1-4 ) 128 - 132 2024.3
-
A Cohort Study of the Influence of the 12-Component Modified Japanese Diet Index on Oral and Gut Microbiota in the Japanese General Population.
Satoshi Sato, Daisuke Chinda, Chikara Iino, Kaori Sawada, Tatsuya Mikami, Shigeyuki Nakaji, Hirotake Sakuraba, Shinsaku Fukuda
Nutrients 16 ( 4 ) 2024.2
-
Helicobacter pylori感染と腸管内細菌叢
飯野 勢, 珍田 大輔, 下山 克
日本ヘリコバクター学会誌 24 145 - 150 2024
-
A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage.
Ninomiya M, Tsuruoka M, Inoue J, Hiraoka A, Iwata T, Sano A, Sato K, Onuki M, Sawahashi S, Kuroda H, Oikawa T, Fujita M, Abe K, Katsumi T, Sato W, Igarashi G, Iino C, Endo T, Tanabe N, Numao H, Iijima K, Matsumoto T, Ohira H, Ueno Y, Masamune A
Scientific reports 13 ( 1 ) 20739 2023.11
-
Helicobacter pylori除菌が腸内細菌叢へ及ぼす影響についてのコホート研究
佐藤 諭, 珍田 大輔, 下山 克, 飯野 勢, 沢田 かほり, 三上 達也, 中路 重之, 櫻庭 裕丈
日本消化器病学会雑誌 120 ( 臨増大会 ) A757 - A757 2023.10
-
Effect of Liver Fibrosis on Oral and Gut Microbiota in the Japanese General Population Determined by Evaluating the FibroScan-Aspartate Aminotransferase Score.
Satoshi Sato, Chikara Iino, Daisuke Chinda, Takafumi Sasada, Tetsuyuki Tateda, Masatoshi Kaizuka, Hiroki Nomiya, Go Igarashi, Kaori Sawada, Tatsuya Mikami, Shigeyuki Nakaji, Hirotake Sakuraba, Shinsaku Fukuda
International journal of molecular sciences 24 ( 17 ) 2023.8
-
今月の臨床 更年期症状への補完代替医療の最新知見-科学的根拠を踏まえて 補完代替医療それぞれの作用機序と効果 -【サプリメント】-エクオールの最新知見
飯野 香理, 飯野 勢, 樋口 毅, 横山 良仁
臨床婦人科産科 77 ( 6 ) 583 - 589 2023.6
-
【更年期症状への補完代替医療の最新知見-科学的根拠を踏まえて】補完代替医療それぞれの作用機序と効果 サプリメント エクオールの最新知見
飯野 香理, 飯野 勢, 樋口 毅, 横山 良仁
臨床婦人科産科 77 ( 6 ) 583 - 589 2023.6
-
A case of hepaticojejunal anastomotic obstruction after a living-donor liver transplantation and recanalization using a high-frequency knife under the rendezvous technique.
Akiko Suto, Keinosuke Ishido, Norihisa Kimura, Taiichi Wakiya, Hidezumi Kikuchi, Chikara Iino, Go Igarashi, Satoshi Sato, Hirotake Sakuraba, Kenichi Hakamada
Clinical journal of gastroenterology 16 ( 5 ) 726 - 731 2023.5
-
家族性大腸腺腫症の十二指腸乳頭部腫瘍に対する内視鏡治療
菊池 英純, 飯野 勢, 五十嵐 剛, 佐藤 諭, 澤田 洋平, 速水 史郎, 太田 真二, 立田 哲也, 蓮井 桂介, 平賀 寛人, 珍田 大輔, 櫻庭 裕丈
Gastroenterological Endoscopy 65 ( Suppl.1 ) 863 - 863 2023.4
-
Helicobacter pylori感染と腸管内細菌叢.
飯野 勢、珍田 大輔、下山 克
日本ヘリコバクター学会誌 24 ( 2 ) 145 - 150 2023.1
-
Association between reactive oxygen species production in neutrophils and liver fibrosis in the general population
Sato Satoshi, Nakaji Shigeyuki, Sawada Kaori, Akimoto Naoki, Tateda Tetsuyuki, Kaizuka Masatoshi, Sasada Takafumi, Nomiya Hiroki, Igarashi Go, Iino Chikara, Chinda Daisuke, Mikami Tatsuya, Sakuraba Hirotake, Fukuda Shinsaku
Journal of Clinical Biochemistry and Nutrition 73 ( 3 ) 214 - 220 2023
-
Helicobacter pylori感染と腸管内細菌叢
飯野 勢, 珍田 大輔, 下山 克
日本ヘリコバクター学会誌 24 145 - 150 2023
-
A Cohort Study of the Effects of Daily-Diet Water-Soluble Dietary Fiber on Butyric Acid-Producing Gut Microbiota in Middle-Aged and Older Adults in a Rural Region.
Satoshi Sato, Daisuke Chinda, Tadashi Shimoyama, Chikara Iino, Sae Kudo, Kaori Sawada, Tatsuya Mikami, Shigeyuki Nakaji, Hirotake Sakuraba, Shinsaku Fukuda
Microorganisms 10 ( 9 ) 2022.9
-
Reduced equol production and gut microbiota features in men with lean nonalcoholic fatty liver disease.
2. Iino C, Endo T, Iino K, Tateda T, Sato S, Igarashi G, Mikami K, Sakuraba H, Yokoyama Y, Nakaji S, Fukuda S.
2022.9
-
Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy
Hidekatsu Kuroda, Takayoshi Oikawa, Masashi Ninomiya, Masashi Fujita, Kazumichi Abe, Kazuo Okumoto, Tomohiro Katsumi, Wataru Sato, Go Igarashi, Chikara Iino, Tetsu Endo, Nobukazu Tanabe, Hiroshi Numao, Shinsaku Fukuda, Katsunori Iijima, Atsushi Masamune, Hiromasa Ohira, Yoshiyuki Ueno, Yasuhiro Takikawa
Liver Cancer 11 ( 4 ) 383 - 396 2022.7
-
Reduced Equol Production and Gut Microbiota Features in Men With Lean Nonalcoholic Fatty Liver Disease
Chikara Iino, Tetsu Endo, Kaori Iino, Tetsuyuki Tateda, Satoshi Sato, Go Igarashi, Kenichiro Mikami, Hirotake Sakuraba, Yoshihito Yokoyama, Shigeyuki Nakaji, Shinsaku Fukuda
American Journal of Men's Health 16 ( 4 ) 155798832211155 - 155798832211155 2022.7